InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Legorreta Pablo G., Director. Director active across 3 companies, notably Royalty Pharma plc. Cumulatively, 20 disclosures have been published. Split: 6 buys · 0 sell. Total volume traded: €95.8m. Activity tracked since 7 May 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Legorreta Pablo G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
65,216 shares0Class A Ordinary SharesSEC:0001507678-26-000006:0
157,828 shares0Class A Ordinary SharesSEC:0001507678-26-000002:0
36,559 shares0Class A Ordinary SharesSEC:0001507678-25-000010:0
21,901 shares0Class A Ordinary SharesSEC:0001802768-25-000105:0
3,823,996 shares0Class A Ordinary SharesSEC:0000950170-25-082342:0
530,348 shares0Class A Ordinary SharesSEC:0001802768-25-000063:0
288,352 shares0Class A Ordinary SharesSEC:0001802768-25-000039:0
532,535 shares0Class A Ordinary SharesSEC:0000950170-25-015495:0
22,617,909 shares@ US$2.42100.0% of flowClass A Ordinary SharesSEC:0000950170-24-073633:0
Canonical exit: 11 Sept 2024 (T+90)
748,952 shares0Class A Ordinary SharesSEC:0000950170-24-011711:0
292,190.49 shares0Class A ordinary sharesSEC:0000950103-23-016404:0
5,289,055 shares0Class A Ordinary SharesSEC:0001209191-23-054044:0
130,000 shares@ US$29.513624.5% of flowClass A ordinary sharesSEC:0001209191-23-040024:0
Canonical exit: 26 Sept 2023 (T+90)
45,000 shares@ US$32.99889.6% of flowClass A ordinary sharesSEC:0001209191-23-036624:0
Canonical exit: 10 Sept 2023 (T+90)
150,000 shares@ US$32.249631.3% of flowClass A ordinary sharesSEC:0000950103-23-007785:0
Canonical exit: 22 Aug 2023 (T+90)
160,388 shares@ US$33.566934.5% of flowClass A ordinary sharesSEC:0000950103-23-007427:0
Canonical exit: 14 Aug 2023 (T+90)
31,933,334 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028860:0
493,750 shares0Class A Ordinary SharesSEC:0000950103-22-006475:0
22,666,667 shares@ US$1.50100.0% of flowCommon StockSEC:0000899243-22-003857:0
Canonical exit: 1 May 2022 (T+90)
1,040,410 shares0Class A Ordinary SharesSEC:0000950103-21-007075:0
20 of 20 declarations
About Legorreta Pablo G.
Legorreta Pablo G. is Chief Executive Officer, Chairman and Director. He has filed 19 filings in total, and across the 19 sampled recent filings the recorded transactions are purchases for EUR 95802560 and no sales, between 2021-05-11 and 2026-02-13. The largest recent filings concern Prokidney CORP., Epizyme, Inc. and Royalty Pharma plc.
